Mouse Mutants of Gpr37 and Gpr37l1 Receptor Genes: Disease Modeling Applications

Int J Mol Sci. 2022 Apr 13;23(8):4288. doi: 10.3390/ijms23084288.

Abstract

The vertebrate G protein-coupled receptor 37 and G protein-coupled receptor 37-like 1 (GPR37 and GPR37L1) proteins have amino acid sequence homology to endothelin and bombesin-specific receptors. The prosaposin glycoprotein, its derived peptides, and analogues have been reported to interact with and activate both putative receptors. The GPR37 and GPR37L1 genes are highly expressed in human and rodent brains. GPR37 transcripts are most abundant in oligodendrocytes and in the neurons of the substantia nigra and hippocampus, while the GPR37L1 gene is markedly expressed in cerebellar Bergmann glia astrocytes. The human GPR37 protein is a substrate of parkin, and its insoluble form accumulates in brain samples from patients of inherited juvenile Parkinson's disease. Several Gpr37 and Gpr37l1 mouse mutant strains have been produced and applied to extensive in vivo and ex vivo analyses of respective receptor functions and involvement in brain and other organ pathologies. The genotypic and phenotypic characteristics of the different mouse strains so far published are reported and discussed, and their current and proposed applications to human disease modeling are highlighted.

Keywords: G protein–coupled receptor; disease model; mouse mutant.

Publication types

  • Review

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Brain / metabolism
  • Humans
  • Mice
  • Neurons / metabolism
  • Parkinsonian Disorders* / metabolism
  • Receptors, G-Protein-Coupled* / metabolism

Substances

  • GPR37L1 protein, human
  • Gpr37 protein, mouse
  • Gpr37l1protein, mouse
  • Receptors, G-Protein-Coupled